During the past decade, Accord Clinical Research, LLC conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 17 clinical trials were completed, i.e. on average, 212.5% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Accord Clinical Research, LLC" #1 sponsor was "Pfizer" with 7 trials, followed by "Mallinckrodt" with 2 trials sponsored, "Shire" with 2 trials sponsored, "Sucampo Pharma Americas, LLC" with 2 trials sponsored and "Axsome Therapeutics, Inc." with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Accord Clinical Research, LLC" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator and "RTI Health Solutions" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Accord Clinical Research, LLC" are "Irritable Bowel Syndrome" (4 trials), "Osteoarthritis" (4 trials), "Osteoarthritis, Hip" (3 trials), "Osteoarthritis, Knee" (3 trials) and "Arthritis" (2 trials). Many other conditions were trialed in "Accord Clinical Research, LLC" in a lesser frequency.

Most popular intervention types in "Accord Clinical Research, LLC" are "Drug" (25 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Lubiprostone" (2 trials), "NSAID" (2 trials), "Naproxen" (2 trials) and "tanezumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Accord Clinical Research, LLC" are 25 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Accord Clinical Research, LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Accord Clinical Research, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Accord Clinical Research, LLC, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".